AU2984000A - Compounds for cardiovascular treatment comprising multi-vitamin and anti-platelet aggregating agents and methods for making and using the same - Google Patents

Compounds for cardiovascular treatment comprising multi-vitamin and anti-platelet aggregating agents and methods for making and using the same

Info

Publication number
AU2984000A
AU2984000A AU29840/00A AU2984000A AU2984000A AU 2984000 A AU2984000 A AU 2984000A AU 29840/00 A AU29840/00 A AU 29840/00A AU 2984000 A AU2984000 A AU 2984000A AU 2984000 A AU2984000 A AU 2984000A
Authority
AU
Australia
Prior art keywords
vitamin
compounds
making
methods
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29840/00A
Inventor
John J. Abbott
Richard Heibel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2984000A publication Critical patent/AU2984000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU29840/00A 1999-02-18 2000-02-07 Compounds for cardiovascular treatment comprising multi-vitamin and anti-platelet aggregating agents and methods for making and using the same Abandoned AU2984000A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09250941 1999-02-18
US09/250,941 US6274170B1 (en) 1999-02-18 1999-02-18 Compounds for cardiovascular treatment comprising multi-vitamin and anti-platelet aggregating agents and methods for making and using the same
PCT/US2000/003133 WO2000048578A1 (en) 1999-02-18 2000-02-07 Compounds for cardiovascular treatment comprising multi-vitamin and anti-platelet aggregating agents and methods for making and using the same

Publications (1)

Publication Number Publication Date
AU2984000A true AU2984000A (en) 2000-09-04

Family

ID=22949818

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29840/00A Abandoned AU2984000A (en) 1999-02-18 2000-02-07 Compounds for cardiovascular treatment comprising multi-vitamin and anti-platelet aggregating agents and methods for making and using the same

Country Status (3)

Country Link
US (1) US6274170B1 (en)
AU (1) AU2984000A (en)
WO (1) WO2000048578A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2191582C2 (en) * 2000-04-05 2002-10-27 Хазанов Вениамин Абрамович Pharmaceutical compositions based on nonsteroid anti-inflammatory agents
US6576256B2 (en) * 2001-08-28 2003-06-10 The Brigham And Women's Hospital, Inc. Treatment of patients at elevated cardiovascular risk with a combination of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin
DE10206159A1 (en) * 2002-02-14 2003-08-28 Kosmas Kg Agent containing folic acid, vitamin B6 and vitamin B12, and their use
FR2847472B1 (en) * 2002-11-22 2006-08-11 Synergia NOVEL PHARMACEUTICAL COMPOSITIONS, IN PARTICULAR FOR THE PREVENTION OF CARDIOVASCULAR PATHOLOGIES
DE20300304U1 (en) * 2003-01-09 2003-04-24 Dr. Gerhard Mann Chem.-pharm. Fabrik GmbH, 13581 Berlin Ocuvite zinc
FR2851920B1 (en) * 2003-03-06 2007-05-04 Larena Sa PRODUCT FOR REDUCING METABOLIC SYNDROME AND USE THEREOF FOR THE PREPARATION OF A FOOD OR DIETETIC COMPOSITION FOR THE PREVENTION OR TREATMENT OF METABOLIC SYNDROME
US7196093B2 (en) * 2003-04-09 2007-03-27 General Atomics Reversible inhibitors of SAH hydrolase and uses thereof
US7517887B2 (en) * 2003-04-09 2009-04-14 General Atomics Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof
US7868011B2 (en) * 2003-04-09 2011-01-11 General Atomics Use of reversible inhibitors of S-adenosyl-L-homocysteine hydrolase for treating lupus
PL1732605T3 (en) * 2004-03-29 2019-09-30 Wyeth Llc Multi-vitamin and mineral nutritional supplements
CA2467894A1 (en) * 2004-05-20 2005-11-20 Medical Futures Inc. A composition for prevention and treatment of colon adenomas
JP2008505126A (en) * 2004-07-07 2008-02-21 メディキュア インターナショナル インコーポレイテッド Combination therapy using platelet aggregating drugs
US20060094749A1 (en) * 2004-10-28 2006-05-04 Medicure International Inc. Substituted pyridoxines as anti-platelet agents
US7459468B2 (en) * 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
CA2585165A1 (en) * 2004-10-28 2006-05-18 Medicure International Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
DE102005001479A1 (en) * 2005-01-12 2006-07-20 Synavit Gmbh Agent containing folic acid, vitamin B6 and vitamin B12, and its use
DE102005009379A1 (en) 2005-03-01 2006-09-07 Synavit Gmbh Agent containing folic acid, vitamin B6 and vitamin B12, and its use
CA2632090A1 (en) * 2005-11-28 2007-05-31 Medicure International Inc. Selected dosage for the treatment of cardiovascular and related pathologies
DK2221059T3 (en) * 2007-10-25 2018-03-12 Nutri Co Ltd Composition for reducing the level of glucose, malondialdehyde-modified LDL, homocysteine and / or c-reactive protein in blood
US8197871B2 (en) * 2009-05-13 2012-06-12 L Europa Gary A Composition for headache treatment
CN102917702A (en) * 2009-09-23 2013-02-06 夏威夷大学 Zinc-containing compositions for the treatment of diseases, illnesses and syndromes associated with exposure to pore forming toxins
US8889157B1 (en) * 2010-08-31 2014-11-18 Gary L'Europa Composition for cardiovascular treatment
US10172883B2 (en) 2014-06-10 2019-01-08 Alatalab Solution, Llc Methods and compositions for treating and/or inhibiting toxins using copper-containing compounds

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1969998A (en) 1932-12-09 1934-08-14 Cal Aspirin Company Combination of salicylic acid and calcium salts
US3914419A (en) 1973-08-02 1975-10-21 American Cyanamid Co Two compartment one unit consecutively injectable liquid vitamin package
GB2142518B (en) 1983-06-16 1987-12-09 Glaxo Group Ltd Infant foods
US5948769A (en) 1984-01-28 1999-09-07 Ismail; Roshdy Agent for treating heart diseases
US5541220A (en) 1984-03-07 1996-07-30 Ismail; Roshdy Agents for the treatment and protection of the skin
US4806354A (en) 1984-04-06 1989-02-21 Green James P Health food composition
CA1218303A (en) 1985-08-21 1987-02-24 Larry Barron Composition for the temporary stimulation of urine production
US4945083A (en) 1986-06-03 1990-07-31 Jansen Jr Christian J Safe oral folic-acid-containing vitamin preparation
US5563126A (en) 1986-11-20 1996-10-08 Metabolite Laboratories Method for treatment and prevention of deficiencies of vitamins B12, folic acid, and B6
ES2043897T3 (en) 1988-01-28 1994-01-01 Koeltringer Peter COMBINATION PREPARATION, ESPECIALLY FOR THE TREATMENT OF NERVOUS CELL DISEASES.
US4937234A (en) 1988-08-10 1990-06-26 Fahim Mostafa S Minerals in bioavailable form
US5733572A (en) 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
US5084482A (en) 1990-04-10 1992-01-28 The Lithox Corporation Methods for inhibiting inflammatory ischemic, thrombotic and cholesterolemic disease response with methionine compounds
US5401730A (en) 1990-07-06 1995-03-28 The Hope Heart Institute Method for reducing platelet aggregation
AP387A (en) 1991-09-13 1995-07-31 Siegbert Heinrich Bissbort Therapeutical uses of L-methionine and compositions thereof.
US5322689A (en) 1992-03-10 1994-06-21 The Procter & Gamble Company Topical aromatic releasing compositions
US5300298A (en) 1992-05-06 1994-04-05 The Pennsylvania Research Corporation Methods of treating obesity with purine related compounds
US5795873A (en) 1992-12-29 1998-08-18 Metabolite Laboratories, Inc. Method for treatment and prevention of deficiencies of vitamins B12, folic acid and B6
US5626883A (en) 1994-04-15 1997-05-06 Metagenics, Inc. Ascorbic acid compositions providing enhanced human immune system activity
US5626884A (en) 1995-08-18 1997-05-06 Lockett; Curtis G. Treatment of sickle cell disease
US5597585A (en) 1995-12-26 1997-01-28 Williams; Andrew H. Vitamin/mineral composition
US5770215A (en) 1997-01-06 1998-06-23 Moshyedi; Emil Payman Multivitamin/vascular occlusion inhibiting composition

Also Published As

Publication number Publication date
US6274170B1 (en) 2001-08-14
WO2000048578A1 (en) 2000-08-24

Similar Documents

Publication Publication Date Title
AU2984000A (en) Compounds for cardiovascular treatment comprising multi-vitamin and anti-platelet aggregating agents and methods for making and using the same
MXPA02001866A (en) Methods useful in affecting apoptosis.
ZA200106058B (en) Polyolefin compositions having variable density and methods for their production and use.
AU2001266583A1 (en) Epothilone derivatives and methods for making and using the same
AU7989400A (en) Compounds and methods
AU5024000A (en) Moru/be multilayers
AU3215500A (en) Compounds and methods
AU7373700A (en) Vascular closure
AU2001280604A1 (en) Compositions comprising icariside i and anhydroicaritin and methods for making the same
AU2001280599A1 (en) Compounds and methods
AU2001253418A1 (en) Compounds and methods
PL366308A1 (en) Absorbent articles and methods for producing the same
AU2002213466A1 (en) Compounds and methods for modulating ccr4 function
AU2002231295A1 (en) Developed seed and methods for making the same
AU6421600A (en) Compacted-powder opposed twin-helical gears and method
AU2001243394A1 (en) Compounds and methods
AU1881001A (en) Programmable convolver
AUPQ872300A0 (en) Compounds and methods
AU1083501A (en) Antibiotic-metal complex and methods
AU2002241739A1 (en) Antimycobacterial compounds and method for making the same
AU2002218903A1 (en) Modified container
AU2001278951A1 (en) Compounds and methods
AU4129500A (en) Reduction gearbox
AU6164800A (en) Level sensor-switch
AU3191100A (en) Ligand-bonded complex

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase